HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recalls With Potential For Serious Health Risks Will Identify Points Of Sale

This article was originally published in The Rose Sheet

Executive Summary

"Certain supply chain information is confidential between the supplier and retailer" and makes it difficult for FDA to release lists of retailers offering recalled supplements and foods, says Commissioner Scott Gottlieb. But a draft guidance says for some Class I cases, which pose reasonable probability of serious adverse health consequences or death, additional information about retailers selling potentially harmful product may be key to protecting consumers.

You may also be interested in...



'Mock' Recalls Suggested, But US FDA Isn't Joking About Recalling Products

FDA's suggestions in voluntary recalls draft guidance largely track with advice attorneys long have offered consumer health product firms. Instead, on top of November guidance on mandatory recall authority and February guidance on recall public notifications, FDA is making clear its expectations for firms' preparedness for recalls and their responses when faced with removing products from store shelves.

FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements

FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.

Injunction Ends Spiked Supplement Marketers' Attempt To Deceive FDA

Other than making apparently false statements to FDA about no longer selling spiked supplements, operators of R Thomas Marketing, identified online as a social media consultancy, and S Hackett Marketing, which d/b/a "Just Enhance" and apparently sells a variety of consumer goods, made no contact with FDA or with DoJ, according to court order entered as a permanent injunction.

Related Content

Topics

UsernamePublicRestriction

Register

RS121865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel